Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA commissioner search: Pittsburgh's Juhl could be politically appealing candidate.

This article was originally published in The Tan Sheet

Executive Summary

FDA COMMISSIONER SEARCH: PITTSBURGH PHARMACY PROFESSOR JUHL, one of the first names being widely discussed as a successor to Commissioner David Kessler, offers a potentially appealing package of attributes for the selection. University of Pittsburgh School of Pharmacy Dean Randy Juhl, PhD, the inaugural chairman of FDA's Nonprescription Drugs Advisory Committee, could be presented as a key participant in the agency's recent efforts to expand consumer access to medicines via the Rx-to-OTC switch process.

You may also be interested in...



NDAC Member Wood Joins FDA Commissioner Candidate List

FDA Nonprescription Drug Advisory Committee member and Vanderbilt University Vice Chancellor Alastair Wood, MD, is one of several new candidates for FDA commissioner being considered by the White House

NDAC Member Wood Joins FDA Commissioner Candidate List

FDA Nonprescription Drug Advisory Committee member and Vanderbilt University Vice Chancellor Alastair Wood, MD, is one of several new candidates for FDA commissioner being considered by the White House

NDAC Member Wood Joins FDA Commissioner Candidate List

FDA Nonprescription Drug Advisory Committee member and Vanderbilt University Vice Chancellor Alastair Wood, MD, is one of several new candidates for FDA commissioner being considered by the White House

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086416

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel